Benzinga's Top Upgrades

Analysts at Compass Point upgraded

from Market Perform to Outperform. The price target for AthenaHealth has been raised from $134 to $172. AthenaHealth's shares closed at $139.85 yesterday. Analysts at JMP Securities upgraded

from Market Perform to Market Outperform. The price target for Myriad Genetics is set to $50. Myriad Genetics' shares closed at $38.12 yesterday. Baird upgraded

from Neutral to Outperform. The price target for Hilton Worldwide has been raised from $28 to $30. Hilton Worldwide's shares closed at $26.57 yesterday. Analysts at Raymond James upgraded

from Outperform to Strong Buy. The price target for Manhattan Associates has been raised from $42 to $52. Manhattan Associates' shares closed at $45.07 yesterday.